The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms
Authors
Keywords
-
Journal
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2022-04-29
DOI
10.1080/00365521.2022.2064725
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study
- (2022) Frederik Cold et al. Cells
- Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection from a Randomized Controlled Trial and Review of the Literature
- (2021) R. E. Ooijevaar et al. Microorganisms
- Functional differentiation related to decomposing complex carbohydrates of intestinal microbes between two wild zokor species based on 16SrRNA sequences
- (2021) Yao Zou et al. BMC Veterinary Research
- Current status of fecal microbiota transplantation for irritable bowel syndrome
- (2021) Magdy El‐Salhy et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Long‐term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome
- (2021) Magdy El‐Salhy et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Faecal microbial transplantation in IBS: ready for prime time?
- (2020) Giovanni Barbara et al. GUT
- Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection
- (2020) Bryce K. Perler et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome
- (2020) Perttu Lahtinen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome with Predominant Abdominal Bloating: Short- and Long-Term Results from a Placebo-Controlled Randomized Trial
- (2020) Tom Holvoet et al. GASTROENTEROLOGY
- FMT in IBS: how cautious should we be?
- (2020) Magdy El-Salhy GUT
- Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
- (2020) Magdy El‐Salhy et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
- (2019) Dabo Xu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome
- (2019) Savanne Holster et al. Clinical and Translational Gastroenterology
- Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial
- (2019) Olga C Aroniadis et al. Lancet Gastroenterology & Hepatology
- Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS)
- (2019) Magdy El-Salhy et al. NEUROPEPTIDES
- Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
- (2019) Zachariah DeFilipp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fecal Microbiota Transplantation for Dysbiosis — Predictable Risks
- (2019) Martin J. Blaser NEW ENGLAND JOURNAL OF MEDICINE
- Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
- (2019) Magdy El-Salhy et al. Nutrients
- Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
- (2019) Magdy El-Salhy et al. GUT
- Dysbiosis in Functional Bowel Disorders
- (2018) Paul Enck et al. ANNALS OF NUTRITION AND METABOLISM
- The Fatigue Assessment Scale
- (2018) Celine Hendriks et al. CURRENT OPINION IN PULMONARY MEDICINE
- Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study
- (2018) Sofie Ingdam Halkjær et al. GUT
- Beneficial effect of butyrate‐producing Lachnospiraceae on stress‐induced visceral hypersensitivity in rats
- (2018) Jindong Zhang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- European consensus conference on faecal microbiota transplantation in clinical practice
- (2017) Giovanni Cammarota et al. GUT
- Butyrate promotes visceral hypersensitivity in an IBS-like model via enteric glial cell-derived nerve growth factor
- (2017) X. Long et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD
- (2015) C. Casén et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Recent developments in the pathophysiology of irritable bowel syndrome
- (2015) Magdy El-Salhy WORLD JOURNAL OF GASTROENTEROLOGY
- Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome
- (2012) T. Banasiewicz et al. Colorectal Disease
- Quality of life measures in irritable bowel syndrome
- (2010) Reuben KM Wong et al. Expert Review of Gastroenterology & Hepatology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now